DAL vs MRSN · P/E 12, rev $35.61B vs rev $40.5M
Delta Air Lines Inc (DAL) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2026-06-30 was $35.61B. Net income was $1.31B. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the DAL and MRSN stock pages for the full models.
Not investment advice.